Socio-economic factors affecting the success of tuberculosis treatment in six counties of Shandong Province, China

Int J Tuberc Lung Dis. 2010 Apr;14(4):440-6.

Abstract

Setting: Tuberculosis (TB) control in rural China is of high priority in health policy making.

Objective: To investigate treatment success among rural TB patients and the determinants of patient and case management and to explore the current status of DOTS implementation in rural China.

Methods: A patient-based study was conducted in six counties of Shandong Province, China. Study sites were selected by multi-stage random sampling. Subjects were rural smear-positive pulmonary TB patients registered with the county TB dispensaries at study sites who completed treatment during the period October 2006 to September 2007.

Results: This study observed a success rate of 74.5% among 501 participants. The cure rate, of 50.5%, was much lower than the national level. There was a difference in treatment success rates across counties. Factors independently affecting treatment success were patient income, study site, and home visits and supervision by town and village health workers.

Conclusions: Enhancing financial resources for TB control and effective involvement of human resources are crucial to achieving success with the DOTS strategy in rural China.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / economics
  • Antitubercular Agents / therapeutic use*
  • Chi-Square Distribution
  • China / epidemiology
  • Directly Observed Therapy
  • Drug Costs
  • Female
  • Financing, Government
  • Health Care Costs
  • Health Care Surveys
  • House Calls
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • National Health Programs* / economics
  • National Health Programs* / statistics & numerical data
  • Program Evaluation
  • Rural Health Services* / economics
  • Rural Health Services* / statistics & numerical data
  • Socioeconomic Factors*
  • Treatment Outcome
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / economics
  • Tuberculosis, Pulmonary / epidemiology

Substances

  • Antitubercular Agents